Blogs and Industry News for Pharmacovigilance & Clinical Operations
5-minute weekly newscast – 26/05/2019
The spotlight is on President Donald Trump who will sign an executive order within the next few days authorizing disclosure of costs across the healthcare industry including drug prices. Big Data and advanced data analytics are revolutionizing the industry. Circuit Clinical, an American based patient-oriented integrated research organization, announced partnership…
Recent Advances in Treatment of Stage IV Metastatic Breast Cancer
Breast cancer is the most common cancer type in women worldwide. It is estimated that 70% of patients with breast cancer are estrogen receptor (ER)-positive, making hormonal therapies using ER antagonists and degraders, such as tamoxifen and fulvestrant, common treatments for breast cancer. However, therapies with ER-independent mechanisms are needed…
5-minute weekly newscast – 19/05/2019
The spotlight is on Gilead, a market leader in HIV treatment, who shared the promising news of donating 2.4 million bottles of Truvada to help ending the HIV epidemic in the United States. Astra Zeneca is implementing artificial intelligence and machine learning for the discovery and development of new treatments for chronic…
Recent Advances in Treatment of Stage IV Metastatic Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Approximately 40% of NSCLC patients are diagnosed with stage IV after the tumor has metastasized. As NSCLC is less sensitive to chemotherapy compared to small cell lung cancer (SCLC), research focus has focused on the development of…
Choosing the Right Immunoassays for Your Radiobiology Experiments
Radiation therapy is one of the most common treatments for cancer. In order to improve the treatment efficacy of radiation therapies, radiobiology is the field of basic research that studies the cellular and molecular biological factors influencing the response of cancerous and normal cell lines to ionizing radiation. In a…
Causality Assessment Methods of Hepatic Adverse Drug Reactions: Opportunities for Enhancement
Joint Event on International Conference on WORLD DRUG DELIVERY AND NOVEL THERAPY SUMMIT & Annual Congress on NEUROSCIENCE & THERAPEUTICS October 25-26, 2018 | Toronto, Canada Conference Date: October 25-26, 2018 Conference Venue: Hotel Park Inn By Radisson Toronto Airport West Address: 175 Derry Rd E, Mississauga, ON L5T 2Z7,…
MD Pharma College (Coming Soon)
Ever since its’ foundation, MD Pharma College has adopted a vision that prepares our STEM graduates to be industry-ready. As a STEM graduate considering a private postsecondary institution to expand your knowledge base on healthcare sciences, you will strongly consider MD Pharma College for the following reasons: MD Pharma College…
Why MD Pharma Consulting Group?
MD Pharma consulting group is a science driven quality focused contract research organization (CRO) that provides innovative consultations and executive solutions to diverse bio-pharmaceutical and medical device industry stakeholders. MD Pharma Consulting Group is a resourceful CRO that employs its’ strategic capabilities towards supporting the development of drugs and medical…
Welcome to MD Pharma Consulting Group
Q: Tell us about yourself A: MD Pharma Consulting Group is a contract research organization (CRO) that provides consultations, plans, and operations to diverse bio-pharmaceutical and medical device industry stakeholders. Q: What is a contract research organization? A: A contract research organization (CRO) is a vendor that provides support to…
- « Previous
- 1
- …
- 436
- 437
- 438







